CN117898956A - Lip-rounding cream composition - Google Patents
Lip-rounding cream composition Download PDFInfo
- Publication number
- CN117898956A CN117898956A CN202410091092.2A CN202410091092A CN117898956A CN 117898956 A CN117898956 A CN 117898956A CN 202410091092 A CN202410091092 A CN 202410091092A CN 117898956 A CN117898956 A CN 117898956A
- Authority
- CN
- China
- Prior art keywords
- lip
- oil
- polyglycerin
- skin
- cream composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 18
- 239000006071 cream Substances 0.000 title claims abstract description 13
- -1 lanosterol compound Chemical class 0.000 claims abstract description 24
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 16
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 13
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 11
- 229940101267 panthenol Drugs 0.000 claims abstract description 11
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 11
- 239000011619 pantothenol Substances 0.000 claims abstract description 11
- JFSQSDAOQLNSQI-DTBJPNGVSA-N 2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-(hexadecanoylamino)-3-methylbutanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O JFSQSDAOQLNSQI-DTBJPNGVSA-N 0.000 claims abstract description 9
- 229940049918 linoleate Drugs 0.000 claims abstract description 9
- 229940077272 palmitoyl hexapeptide-12 Drugs 0.000 claims abstract description 9
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 claims abstract description 8
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 claims abstract description 8
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 claims abstract description 8
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 claims abstract description 8
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 claims abstract description 8
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 claims abstract description 8
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 8
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940058690 lanosterol Drugs 0.000 claims abstract description 8
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims abstract description 8
- 229940059463 sesame seed extract Drugs 0.000 claims abstract description 8
- QZLXCFQVOCEKSX-NOCHOARKSA-N (2s,4r)-1-hexadecanoyl-4-hexadecanoyloxypyrrolidine-2-carboxylic acid Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H]1C[C@@H](C(O)=O)N(C(=O)CCCCCCCCCCCCCCC)C1 QZLXCFQVOCEKSX-NOCHOARKSA-N 0.000 claims abstract description 7
- 239000000539 dimer Substances 0.000 claims abstract description 7
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 claims abstract description 7
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002253 acid Substances 0.000 claims abstract description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 5
- 229940067606 lecithin Drugs 0.000 claims abstract description 5
- 235000010445 lecithin Nutrition 0.000 claims abstract description 5
- 239000000787 lecithin Substances 0.000 claims abstract description 5
- 235000019198 oils Nutrition 0.000 claims abstract description 4
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims abstract description 3
- 229940014041 hyaluronate Drugs 0.000 claims abstract description 3
- 239000002904 solvent Substances 0.000 claims description 11
- 229920002674 hyaluronan Polymers 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 7
- 230000008439 repair process Effects 0.000 claims description 7
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 6
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims description 6
- 229930186217 Glycolipid Natural products 0.000 claims description 6
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 210000002374 sebum Anatomy 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 239000004166 Lanolin Substances 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 235000006708 antioxidants Nutrition 0.000 claims description 5
- 210000002615 epidermis Anatomy 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- 229940039717 lanolin Drugs 0.000 claims description 5
- 235000019388 lanolin Nutrition 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000005846 sugar alcohols Polymers 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 238000005728 strengthening Methods 0.000 claims description 3
- 235000013311 vegetables Nutrition 0.000 claims description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 claims description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- 241000218993 Begonia Species 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 2
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 2
- 244000044822 Simmondsia californica Species 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 2
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 claims description 2
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 235000019868 cocoa butter Nutrition 0.000 claims description 2
- 229940110456 cocoa butter Drugs 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 239000008169 grapeseed oil Substances 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- 235000020778 linoleic acid Nutrition 0.000 claims description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
- 229960004488 linolenic acid Drugs 0.000 claims description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 2
- 239000010466 nut oil Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 229940116351 sebacate Drugs 0.000 claims description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 claims description 2
- 229940057910 shea butter Drugs 0.000 claims description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 2
- 229940032094 squalane Drugs 0.000 claims description 2
- 235000020238 sunflower seed Nutrition 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- SMYKBXMWXCZOLU-UHFFFAOYSA-N tris-decyl benzene-1,2,4-tricarboxylate Chemical compound CCCCCCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCCCCC)C(C(=O)OCCCCCCCCCC)=C1 SMYKBXMWXCZOLU-UHFFFAOYSA-N 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940099549 polyglycerin-3 Drugs 0.000 claims 2
- 229940110977 polyglycerin-4 Drugs 0.000 claims 2
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 6
- 235000010323 ascorbic acid Nutrition 0.000 abstract description 2
- 239000011668 ascorbic acid Substances 0.000 abstract description 2
- 235000002378 plant sterols Nutrition 0.000 abstract 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 60
- 238000012360 testing method Methods 0.000 description 45
- 230000000694 effects Effects 0.000 description 28
- 239000000047 product Substances 0.000 description 25
- 239000000523 sample Substances 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 11
- 230000037394 skin elasticity Effects 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000003020 moisturizing effect Effects 0.000 description 10
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 102000016942 Elastin Human genes 0.000 description 5
- 108010014258 Elastin Proteins 0.000 description 5
- 229920002549 elastin Polymers 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- 229940099552 hyaluronan Drugs 0.000 description 4
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 4
- 229960002591 hydroxyproline Drugs 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000008591 skin barrier function Effects 0.000 description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010040914 Skin reaction Diseases 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960002504 capsaicin Drugs 0.000 description 3
- 235000017663 capsaicin Nutrition 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 230000035483 skin reaction Effects 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 2
- 108010016731 PPAR gamma Proteins 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 229940044176 ceramide 3 Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 210000000229 preadipocyte Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- NOOYIVIUEHDMSF-PKLMIRHRSA-N (2r)-1-phenyl-n-(3-phenylpropyl)propan-2-amine;hydrochloride Chemical compound Cl.C([C@@H](C)NCCCC=1C=CC=CC=1)C1=CC=CC=C1 NOOYIVIUEHDMSF-PKLMIRHRSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 206010024552 Lip dry Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000000536 PPAR gamma Human genes 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 208000020369 Polymerase proofreading-related adenomatous polyposis Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000011759 adipose tissue development Effects 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000019305 fibroblast migration Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Abstract
The invention belongs to the technical field of cosmetic science in the light industry, and particularly relates to a lip cream composition. The composition and weight percentage of the plant sterol and lanosterol compound are, respectively, 1-8% of panthenol, 0.1-0.5% of stearyl glycyrrhetinate, 2-8% of plant sterol isostearyl dimer linoleate, 1-8% of C 10‑30 acid cholesterol/lanosterol compound ester, 0.1-0.5% of hydroxypropyl dipalmitoyl amide MEA, 2-10% of white pond flower seed oil, 0.05-0.5% of phosphatidylcholine (oil soluble lecithin), 0.005-0.1% of palmitoyl hexapeptide-12, 0.01-0.1% of hyaluronate, 0.03-1% of sesame seed extract, 0.5-3% of dipalmitoyl hydroxyproline, 0.5-3% of ascorbic acid tetraisopalmitate and the balance of basic auxiliary materials.
Description
Technical field:
the invention belongs to the technical field of cosmetic science in the light industry, and particularly relates to a lip cream composition.
The background technology is as follows:
Lip-rounding lip products on the market are mainly divided into four main categories. The first type is a physical visual effect, and the effect of physically filling the lips is achieved by using high molecular compounds such as organosilicon elastomer, elastomer gel, hydroxyethyl cellulose hydrogel, chitosan and the like. Such materials do not last when rinsed away. The second is to use capsaicin or similar components to promote the expansion of capillary blood vessels in lips, and bring about slight swelling feeling to lips, so as to achieve the effect of lip enlargement. Capsaicin, however, is a pungent and irritating substance that stimulates the epithelial cells of the oral mucosa, resulting in the mucosa falling off. The third category is grease, such as vaseline, mineral oil, jojoba oil, etc., which can retain lip moisture and prevent evaporation of moisture due to its sealing property, so as to achieve the effect of moisturizing and enlarging lips. However, long-term use may cause the lips to become drier, as the mineral oil may form a film on the lips, preventing moisture ingress. The fourth category is the injection category, e.g. hyaluronic acid. However, injection of hyaluronic acid into the lips requires relatively high medical certification qualification, which is otherwise liable to cause inflammation or skin infection.
The invention comprises the following steps:
The invention aims at the problems and provides a lip cream composition.
In order to achieve the aim, the invention adopts the following technical proposal that the constituents and weight percentages are, panthenol 1-8%, stearyl glycyrrhetinate 0.1-0.5%, phytosterol isostearyl dimer linoleate 2-8%, C 10-30 acid cholesterol/lanosterol mixed ester 1-8%, hydroxypropyl dipalmitin MEA 0.1-0.5%, white pond flower seed oil 2-10%, phosphatidylcholine (oil soluble lecithin) 0.05-0.5%, palmitoyl hexapeptide-12 0.005-0.1%, hyaluronan 0.01-0.1%, sesame seed extract 0.03-1%, dipalmitoyl hydroxyproline 0.5-3%, ascorbyl tetraisopalmitin 0.5-3%, and the balance of basic auxiliary materials;
Panthenol and stearyl glycyrrhetinate are anti-inflammatory repair actives;
Phytosterol isostearyl dimer linoleate, C 10-30 acid cholesterol/lanosterol mixed ester, hydroxypropyl dipalmitoamide MEA, begonia seed oil, and phosphatidylcholine (oil-soluble lecithin) are substances for strengthening lip epidermis sebum membrane;
Palmitoyl hexapeptide-12, acetylated hyaluronic acid, sesame seed extract, dipalmitoyl hydroxyproline, and ascorbyl tetraisopalmitate are anti-wrinkle lip-rounding active substances.
The basic auxiliary materials comprise 15-30% of solvent, 3-8% of solubilizer, 15-40% of humectant, 0.1-0.5% of antioxidant and 0.1-1% of polyalcohol preservative.
The solvent is one or more of caprylic/capric triglyceride, diisostearyl malate, tridecyl trimellitate, dipentaerythritol tri-polyhydroxystearate and glycolipid.
The solubilizer is one or more of polyglycerol-2 isostearate, polyglycerol-3 triisostearate, sodium dodecyl sulfate, polyglycerol-4 isostearate, polyglycerol-4 diisostearate/polyhydroxystearate/sebacate, tween 80, tween 20, sorbitan sesquioleate, sorbitan sesquiisostearate, polyglycerol-3 polyricinoleate, polyglycerol-6 polyricinoleate, polyglycerol-2 triisostearate, polyglycerol-2-dimerized hydroxystearate, oleic acid/linoleic acid/linolenic acid polyglycerol ester.
The humectant is one or more of panthenol, glycerol, lanolin, phytosterol, white pool flower seed oil, jojoba oil, plant squalane, sunflower seed oil, castor oil, coconut oil, shea butter, grape seed oil, macadamia nut oil, olive oil, palm oil, cocoa butter, jojoba butter, glycolipid, octyl dodecanol, caprylic capric triglyceride, coco alcohol-caprylic capric triglyceride and polyglycerol-2 isostearate/dimerized linoleate copolymer.
The antioxidant is one or more of oil-soluble vitamin E acetate, vitamin E and oryzanol.
The polyalcohol preservative is one or more of ethylhexyl glycerol, octyl glycol, 1, 2-pentanediol and p-hydroxyacetophenone.
The invention has the beneficial effects that:
in the raw materials selected by the invention, the panthenol indirectly inhibits the generation of free radicals by promoting the synthesis of intracellular coenzyme A, so as to resist the problem of inflammation, and meanwhile, the panthenol is a humectant with stronger permeability, can enter a structure with deeper epidermis layer, is easy to absorb, and ensures that the skin has natural luster. The stearyl glycyrrhetinate has strong anti-inflammatory and antibacterial effects, can inhibit capillary permeability, can prevent brittle lip from cracking when being used in lip products, has anti-inflammatory, antibacterial, astringent and antioxidant effects, and can effectively improve lip skin problems.
The white pool flower seed oil is one of the most stable vegetable oils in the world because the white pool flower seed oil contains more than 98% of long-chain fatty acid with antioxidation. The white pond flower seed oil can help the lip skin to moisturize and supplement water, help the fallen lips to dead skin, and relieve the damaged lip skin so as to moisten the skin. Phosphatidylcholine is a precursor of acetylcholine and a main component of lipids in cell membranes, and can be directly metabolized into choline, fatty acid and glycerol in vivo, and can be used for improving fat accumulation condition of lip parts, thereby achieving lip-rounding effect. Hydroxypropyl dipalmitoamide MEA is a synthetic ceramide, has a relieving effect on mild and moderate atopic dermatitis AD, and has a good restoration force on lip skin, which is about 50 times as high as that of natural ceramide 3. The phytosterin isostearyl dimer linoleate is a synthetic ceramide, contains a non-hydroxyl, hydroxyl or hydroxyl fatty acid structure connected by sphingosine or phytosphingosine amide bonds, has moisturizing and repairing effects compared with ceramide 3 of natural sources, and has the characteristics of repairing lip skin barrier, resisting aging, repairing lip vein, activating skin barrier, moisturizing, no irritation and the like. The sesame seed extract can activate PPAP gamma (PPAR gamma is a main regulator of adipogenesis), promote differentiation of preadipocytes into mature adipocytes, and improve the ability of the preadipocytes to synthesize and store lipids, thereby reducing wrinkles and making lips plump. And activating PPARgamma can also play an anti-inflammatory role, improve the more serious redness phenomenon caused by the increase of the age, enhance the skin moisture and improve the wrinkles and the skin state. The C10-30 acid cholesterol/lanosterol mixed ester is a mixture of various esters and is characterized in that the branched fatty acid, cholesterol and related substances combined sterols exist in the sterol structure to enhance the water binding, and the branched fatty acid ester has excellent diffusion characteristic, adhesive force and touch feeling. Meanwhile, the skin conditioning lipid has the functions of moisturizing and skin elasticity. Since it is similar to natural skin lipid ingredients, it has the properties of maintaining skin elasticity, moisturizing skin, softening skin and moisturizing skin. The hyaluronan is obtained by acetylation reaction of natural moisturizing factor sodium Hyaluronate (HA), so that the hyaluronan HAs hydrophilicity and lipophilicity, plays the biological activity functions of double moisturizing, repairing cutin barrier, improving skin elasticity and the like, improves the dry and rough state of lip skin, and enables the skin to be soft and elastic.
Palmitoyl hexapeptide-12 is composed of amino acid repetitive sequences existing in elastin, so that the palmitoyl hexapeptide-12 can induce the generation of natural elastin in fibroblast and human skin, endow lip skin with tightening effect, reduce the formation of wrinkles and fine lines, strengthen the natural barrier function of skin, and stimulate the proliferation of fibroblast in dermis and the generation of elastin and collagen. And promote fibroblast migration, so that the wound heals rapidly. Ascorbyl tetraisopalmitate is a vitamin C derivative, is more stable than vitamin C, is oil-soluble, has excellent transdermal absorbability, and can promote collagen synthesis and inhibit collagen degrading enzyme activity.
The diisopalmitoyl hydroxyproline is formed by combining oil-soluble palmitic acid and hydroxyproline, so that skin elasticity can be recovered, and dry lines and fine lines on lips can be reduced. Because hydroxyproline is one of important components for forming a 3D protein structure, the hydroxyproline has an important function in maintaining the three-dimensional structures of collagen, elastin and the like, and can plump the lip structure and reduce the lip volume. Vegetable lanolin (bis-diglycerol polyacyl adipate-2) is generally used as a substitute for unstable animal lanolin and has high water-locking properties. It has excellent skin adhesion and smoothness, and can increase product luster. The glycolipid is derived from natural fiber and sucrose, and can promote the fitting ability of the product on skin and lips, reduce skin moisture evaporation, realize effective moisture retention, and exhibit natural luster from inside to outside.
The invention achieves the effect of anti-inflammatory repair of lip skin by adding panthenol and stearyl glycyrrhetinate; the combination of the phytosterin isostearyl alcohol dimer linoleate, the C10-30 acid cholesterol/lanosterol mixed ester, the hydroxypropyl double palmitoamide MEA, the white pond flower seed oil and the phosphatidylcholine (oil-soluble lecithin) achieves the effect of strengthening the epidermal sebum membrane of the lips, and reduces the evaporation of water on the surfaces of the lips and the loss rate of percutaneous water loss; the effects of anti-wrinkle and lip-rounding are achieved mainly from three dimensions of epidermis, dermis and fat layer, specifically, the moisturizing effect of acetylated hyaluronic acid and panthenol epidermal layer, the proliferation effect of palmitoyl hexapeptide-12, dipalmitoyl hydroxyproline and ascorbate tetraisopalmitate on skin dermis fibroblast and the promotion effect of collagen/elastin, and the proliferation effect of sesame seed extract on fat layer cells.
The invention has no mineral oil and petrochemical source. Specifically, the solvent does not contain silicone solvents of fossil origin such as silicone oil, modified silicone oil, phenyl silicone oil, and the like, and does not contain paraffin mixtures of petrochemical origin such as polyisobutylene, hydrogenated polyisobutylene, isododecane, isohexadecane, polydimethylsiloxane, cyclopentadimethicone, and the like. Is mild and has no irritation, and is friendly to lip skin mucosa. The composition is characterized by containing no active substances such as capsaicin, thermosensitive agents and the like which stimulate skin mucous membrane redness and swelling to cause lip enlargement effect, containing no substances which stimulate mucous membrane, such as alpha-hydroxy acid, retinol/vitamin A and other high active substances, and containing no organic solvents such as ethanol and the like. The used grease is light grease, is fresh and easy to push away, is not sticky and greasy, and does not cause lip burden. Anti-inflammatory repair, reducing percutaneous water loss, and inhibiting inflammatory factors of various skins of cheilitis. Is characterized by the rise of the water content of the lip skin and the reduction of the percutaneous water loss rate (indirectly proving the repairing effect). Establishing a skin barrier: the sebum membrane makes the fragile lip skin more resistant to external stimuli and invasion. The lip is not easy to dry and peel, has strong resistance to environmental changes, and does not cause the conditions of dry cracking, bleeding and the like. The anti-wrinkle lip-rounding and lip-rounding effects are achieved, the volume area and depth of the lip lines are reduced, and the instant and long-acting effects are achieved. Is embodied by an increase in lip skin elasticity, a plump lip, and a reduced lip streak (visualized picture).
In conclusion, the invention has the effects of repairing dry lips, skin, aging, inflammation, skin barrier and the like, and is specifically expressed in the following steps: the cosmetic has the advantages of increasing the moisture content of the lip skin, reducing the percutaneous water loss rate of the lip skin, improving the glossiness of the lip, enhancing the elasticity of the lip skin and the like, and is mild and irritative, and especially has the further requirement of consumers with lip problems on functional lip cosmetics, has innovation and novelty in the market of lip products, namely the fine products, and has strong product competitiveness.
Description of the drawings:
FIG. 1 is a physical view of the lip cream prepared in example 1.
Fig. 2 is a graph of the effect of the sample clinical test volunteer A1 of example 1, wherein a is a graph before the product is applied, b is a graph after the product is applied for 5min, and c is a graph after the product is applied for 24h.
Fig. 3 is a graph of the effect of the sample of example 1 on clinical test volunteer A2, where a is a graph before the product is applied, b is a graph after 5min of the product is applied, and c is a graph after 24h of the product is applied.
Fig. 4 is a graph of the effect of the sample clinical test volunteer A3 of example 1, wherein a is a graph before the product is applied, b is a graph after the product is applied for 5min, and c is a graph after the product is applied for 24h.
Fig. 5 is a graph of the effect of the sample of example 1 on clinical test volunteer A4, where a is a graph before the product is applied, b is a graph after 5min of the product is applied, and c is a graph after 24h of the product is applied.
The specific embodiment is as follows:
Examples 1 to 3
The specific compositions and proportions of examples 1-3 and comparative examples 1-4 are shown in Table 1 below.
TABLE 1
The preparation process of the above-mentioned embodiment is that,
1. Adding the material in the phase A into a reaction kettle, heating to 60-70 ℃, stirring for 10-30 min at the speed of 50-80 r/min, homogenizing for 2-10 min, and rotating at the speed of 2000-3500r/min until the material is completely and uniformly dispersed.
2. Pre-dissolving the raw materials in the phase B, heating to 60-70 ℃, and stirring at a speed of 50-80 r/min until the raw materials are completely and uniformly dissolved; the materials in the phase C are dissolved in advance, and the stirring speed is 50-80 r/min at room temperature until the materials are completely dissolved and transparent.
3. Adding the phase A material into the phase B material, continuously stirring until the material is transparent, cooling to 40-45 ℃, pumping the material premixed in the phase C pot into the reaction pot, continuously stirring, keeping the temperature, and stirring for 10-30 min.
4. Finally cooling to 25-35 ℃, checking, filtering and discharging.
Test results:
1. Patch test
Detecting items: human safety and efficacy evaluation and detection project
The detection basis is as follows: cosmetic safety technical Specification (2015 edition)
Number of test persons: 30 persons, 15 men and 15 persons, and age 25-69 years, average age 38.50+ -2.50 years, meet the volunteer selection criteria of the subject.
Negative control: blank space
Plaque test method: selecting qualified plaque test equipment, placing about 0.020-0.025 mL (liquid) of a test object into the plaque test equipment by a closed plaque test method, applying a hypoallergenic tape to the inner side of the arm of a subject by external application, removing the test object after 24 hours, observing skin reaction after 0.5 hours, 24 hours and 48 hours respectively, and recording according to skin reaction grading standards in the current effective technical specifications, wherein the results are shown in Table 2.
TABLE 2 summary of test results of human skin Patch of cosmetics
The results of the human skin patch test in Table 2 show that 30 subjects in the samples of examples 1-3 and comparative examples 1-4 all had negative skin reactions and the subsequent human clinical efficacy test was continued.
2. Human body test
The using method comprises the following steps: a proper amount of sample is smeared on the lip by a cotton swab and pushed until absorption.
Test time: t0 before application, and 5min and 24h after application.
Frequency of use: only once within 24 hours.
Test purpose: the test specimens were tested for moisture retention, repair, wrinkle resistance, and gloss on lips.
Test environment: the temperature is 21+/-1 ℃, the humidity is 50+/-10% RH
The test method refers to: 1) Cosmetic safety specifications (2015 edition); 2) QB/T4256-2011 cosmetic moisturizing efficacy evaluation guidelines; 3) T/ZHCA 003-2018 cosmetic affects the transepidermal water loss test method; 3) tzhca 005 cosmetic products 005-2019 influence the skin elasticity test method.
The testing process comprises the following steps:
d0 (first day before sample use to visit)
1) Subject information registration, namely completing the knowledge and signing of the informed consent form, and screening the subjects by laboratory technicians according to the enrollment and exclusion criteria;
2) The subject cleans the lips (ensuring that no lip related products are applied), and sits still in a laboratory at a temperature of 21±1 ℃,50±10%rh for 30min;
3) Test subject lip base value: corneometer for skin cuticle moisture content, TEWAMETER for skin transepidermal moisture loss rate, glossymeter GL for gloss, cutometer for elasticity, VC20 for photographing and analyzing smoothness and roughness;
4) A laboratory technician directs the subject to use the sample according to the sample use requirement and the use site, and provides written test notes and instructions for use;
5) The subjects smeared the samples on site and were sitting still for 5min before the first round of testing.
24H (visit again after 24h after sample application)
1) The subject cleansed the lips skin and sat for 30min in a laboratory at a temperature of 21±1 ℃,50±10%rh;
2) Data values for test subjects lip 24 h: corneometer for skin cuticle moisture content, TEWAMETER for skin transepidermal moisture loss rate, glossymeter GL for gloss, cutometer for elasticity, VC20 for photographing and analyzing smoothness and roughness;
3) The subject filled in a self-questionnaire.
1. Skin feel test
TABLE 3 skin feel score results for subjects using the products (24 h after each sample was used)
Remarks: the higher the evaluation score, the higher the satisfaction
As can be seen, example 2 was less satisfactory in terms of the degree of tackiness than others, because the active glycolipid used in example 2 was higher in terms of the viscous material, and the remaining examples were less different in terms of the degree of adhesiveness and satisfaction than the comparative examples.
2. Skin moisture content
The test indexes are as follows: moisture content of skin stratum corneum
Test instrument: corneometer for skin moisture tester
Testing: 5min,24h
Measurement area: lip portion
The principle of the test is based on the fact that the dielectric constant (< 7) of water (81) and other substances varies considerably, and that a properly shaped measuring capacitor varies with the capacitance of the skin, which is in the measuring range, according to the moisture content, so that the moisture content of the skin can be measured.
TABLE 4 Table 4
As can be seen from table 4, after the test subjects continuously used the samples of example 1, the lip moisture content was increased by 51.63% and 42.54% respectively from the base values after using the products for 5min and 24 h; next, example 2 and example 3. Comparative example 1 had the least effective, and comparative examples 2, 3, and 4 had less effective than examples.
3. Skin percutaneous moisture loss rate
The test indexes are as follows: skin percutaneous water loss
Test instrument: skin moisture loss tester TEWAMETER
Test period: 5min and 24h
Test part: lip portion
The test principle is as follows: derived from Fick's law of diffusion: dm/dt= -d·a· (dp/dx) dm/dt-the amount of water evaporated per hour, D-constant, a-area, dp/dx-the pressure difference between the upper and lower sensors mmHg.
Test value interpretation: the lower the percutaneous loss rate, the better the repair effect.
TABLE 5
As can be seen from Table 5, the skin moisture loss value of the lips was reduced by 0.8% and 8.72% respectively from the base value after the sample of example 1 was used for 5min and 24h, which indicates that the skin moisture loss value has obvious repairing effect. Example 2 decreased by 1.20% and 9.23%, respectively, with more remarkable effect, probably due to higher addition of active. The next is a drop of 0.70% and 7.44% for example 3, respectively. Comparative example 1 and comparative example 3 are poor in effect and may be effective active materials lacking in sebum membrane repair, such as white pool flower seed oil, phosphatidylcholine, lanolin, phytosterin isostearyl dimer linoleate, and the like, which have the effect of repairing lip sebum membrane.
4. Rate of change of skin elasticity
Test instrument: skin elasticity tester MPA580 (Coura+Khazaka, germany)
Test time: 5min and 24h
Skin elasticity parameters were measured using a skin elasticity tester and the rate of change of skin elasticity was calculated.
TABLE 6
As can be seen from Table 6, after the sample of example 1 was used for 5min and 24h, the lip elasticity was improved by 35.1% and 23.06% respectively, and the sample of example 2 was improved by 35.87% and 23.44% respectively, because of higher content of anti-wrinkle active substance, the elasticity improvement rate was higher. The comparative example 1 and comparative example 4 have low elastic change rates, and may lack anti-wrinkle materials such as palmitoyl hexapeptide-12, hyaluronan, ascorbyl tetraisopalmitate, dipalmitoyl hydroxyproline, and sesame seed extract.
5. Skin gloss variation
The test principle is as follows: skin surface gloss is reflected by direct and diffuse reflection of light impinging on the skin surface. A parallel beam of white light generated by an LED at the tip of the probe is directed at the skin surface at an angle of 60 after passing through a planar mirror, and a portion of the light is directed at the same angle after being reflected directly through another planar mirror to a receiving transducer. Another part of the light is scattered by the skin surface and received by a sensor positioned in the vertical direction of the skin. The skin gloss test probe GL200 can thus test not only the light directly reflected by the skin in relation to the gloss, but also the light scattered by the skin.
Test instrument: glossymeter GL200 probe GL200 is specifically used to test the gloss of skin surfaces because the skin differs not only in structure and brightness, but also in color, so by testing the reflected and scattered light from the skin surface of the lips, the gloss of different skins can be accurately and conveniently tested.
Test part: lip portion
TABLE 7
As can be seen from table 7, the lip gloss was improved by 3.88% from the base value after 5min of the product used in the sample of example 1; example 2 improved by 4.01% after 5min, followed by 3.56% in example 3; the comparative example showed a smaller change rate, and the amount of grease added was probably small. While after 24 hours of use of all products (including examples and comparative examples) there was no significant difference in lip gloss from the base value.
The foregoing is merely exemplary embodiments of the present invention and are not intended to limit the scope of the present invention, and all equivalent modifications made by the present invention or direct or indirect application in the relevant art are intended to be included in the scope of the present invention.
Claims (7)
1. A lip cream composition is characterized by comprising, by weight, 1-8% of panthenol, 0.1-0.5% of stearyl glycyrrhetinate, 2-8% of phytosterol isostearyl dimer linoleate, 1-8% of C 10-30 cholesterol/lanosterol mixed ester, 0.1-0.5% of hydroxypropyl dipalmitin MEA, 2-10% of white pool flower seed oil, 0.05-0.5% of phosphatidylcholine, 0.005-0.1% of palmitoyl hexapeptide-12, 0.01-0.1% of hyaluronate, 0.03-1% of sesame seed extract, 0.5-3% of dipalmitoyl hydroxyproline, 0.5-3% of tetraisopalmitin and the balance of basic auxiliary materials;
Panthenol and stearyl glycyrrhetinate are anti-inflammatory repair actives;
Phytosterol isostearyl dimer linoleate, C 10-30 acid cholesterol/lanosterol mixed ester, hydroxypropyl dipalmitoamide MEA, begonia seed oil, and phosphatidylcholine (oil-soluble lecithin) are substances for strengthening lip epidermis sebum membrane;
Palmitoyl hexapeptide-12, acetylated hyaluronic acid, sesame seed extract, dipalmitoyl hydroxyproline, and ascorbyl tetraisopalmitate are anti-wrinkle lip-rounding active substances.
2. The lip cream composition according to claim 1, wherein the basic auxiliary materials comprise solvent, solubilizer, humectant, antioxidant and polyalcohol preservative, and the weight ratio of the basic auxiliary materials in the whole composition is 15-30%, the solubilizer is 3-8%, the humectant is 15-40%, the antioxidant is 0.1-0.5%, and the polyalcohol preservative is 0.1-1%.
3. The lip cream composition according to claim 2, wherein the solvent is one or more of caprylic/capric triglyceride, diisostearyl malate, tridecyl trimellitate, dipentaerythritol tri-polyhydroxystearate, and glycolipid.
4. The lip cream composition according to claim 2, wherein the solubilizing agent is one or more of polyglycerin-2 isostearate, polyglycerin-3 triisostearate, sodium lauryl sulfate, polyglycerin-4 isostearate, polyglycerin-4 diisostearate/polyhydroxystearate/sebacate, tween 80, tween 20, sorbitan sesquioleate, sorbitan sesquiisostearate, polyglycerin-3 polyricinoleate, polyglycerin-6 polyricinoleate, polyglycerin-2 triisostearate, polyglycerin-2-dimerhydroxystearate, oleic acid/linoleic acid/linolenic acid polyglycerin.
5. The lip cream composition according to claim 2, wherein the humectant is one or more of panthenol, glycerin, vegetable lanolin, phytosterol, white pool seed oil, jojoba oil, vegetable squalane, sunflower seed oil, castor oil, coconut oil, shea butter, grape seed oil, macadamia nut oil, olive oil, palm oil, cocoa butter, jojoba butter, glycolipid, octyldodecanol, caprylic capric triglyceride, coco-caprylic capric triglyceride, polyglycerin-2 isostearate/dimerlinoleate copolymer.
6. The lip cream composition according to claim 2, wherein the antioxidant is one or more of oil-soluble vitamin E acetate, vitamin E, oryzanol.
7. The lip cream composition according to claim 2, wherein the polyol preservative is one or more of ethylhexyl glycerol, octyl glycol, 1, 2-pentanediol, and p-hydroxyacetophenone.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410091092.2A CN117898956A (en) | 2024-01-23 | 2024-01-23 | Lip-rounding cream composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410091092.2A CN117898956A (en) | 2024-01-23 | 2024-01-23 | Lip-rounding cream composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117898956A true CN117898956A (en) | 2024-04-19 |
Family
ID=90683662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410091092.2A Pending CN117898956A (en) | 2024-01-23 | 2024-01-23 | Lip-rounding cream composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117898956A (en) |
-
2024
- 2024-01-23 CN CN202410091092.2A patent/CN117898956A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1028705B1 (en) | Uses of d-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells | |
CN109846757B (en) | Sebum biomimetic composition and cosmetic containing same | |
BR112018011558B1 (en) | Composition, cosmetic use of a composition, cosmetic process for treating keratin materials and cosmetic treatment process | |
EA023290B1 (en) | Method of treating skin and topical composition for rejuvenating, replenishing and firming skin during sleep | |
CN111789777A (en) | Skin care cream with immediate tightening and anti-aging effects and preparation method thereof | |
KR20140045397A (en) | Lip stick | |
CN110974767A (en) | Composition for skin barrier regeneration repair and application thereof | |
US20110021439A1 (en) | Use of transesterified olive oil in the cosmetic field | |
WO2011065772A2 (en) | Water in oil type cosmetic composition for improving skin | |
CN111973490A (en) | Skin care cosmetic with liquid crystal structure | |
CN110433113A (en) | A kind of essence dew and preparation method containing the anti-ageing composition of moisturizing | |
CN109223588A (en) | A kind of replenishing water and preserving moisture cosmetics | |
CN109528540A (en) | A kind of eye essence composition of mild anti-aging | |
CA2326528C (en) | Cholesterol sulfate compositions for artificial skin tanning | |
CN111297760A (en) | Composition with repairing effect and application thereof | |
CN114272172B (en) | Whitening and soothing composition and preparation method thereof | |
CN110075003A (en) | A kind of moisturizing content in freckle cream and preparation method thereof containing beta glucan | |
WO2022013897A1 (en) | Dermatological composition for rebalancing the skin, for increasing its hydration and elasticity and for reducing dynamic disorders | |
CN111388394B (en) | Biphase freeze-dried powder solvent and preparation method and application thereof | |
CN112641669A (en) | Composition with skin moisturizing and tightening functions and application thereof | |
JPS63150209A (en) | Skin cosmetic | |
CN115006274B (en) | Water-oil biphase skin softening water added with blue copper peptide and preparation method thereof | |
CN115154375B (en) | Stable cleaning composition with repairing and relieving effects | |
KR102036141B1 (en) | Cosmetic Composition Containing Cholesteric Liquid Crystal With Dual Capsule Process | |
CN117898956A (en) | Lip-rounding cream composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication |